Investigating chronic lung infections caused by Mycobacterium avium complex
Mycobacterium avium complex Core Outcomes Research (MACCOR)
['FUNDING_OTHER'] · OREGON HEALTH & SCIENCE UNIVERSITY · NIH-10894740
This study is looking at how to better understand and measure the effects of pulmonary Mycobacterium avium complex (MAC) on patients, so we can improve treatments and help people feel better and live healthier lives.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | OREGON HEALTH & SCIENCE UNIVERSITY (nih funded) |
| Locations | 1 site (PORTLAND, UNITED STATES) |
| Trial ID | NIH-10894740 on ClinicalTrials.gov |
What this research studies
This research focuses on pulmonary Mycobacterium avium complex (MAC), a chronic infection that leads to airway inflammation and affects patients' overall health and quality of life. The study aims to develop better outcome measures to assess the impact of this disease, as current methods are inadequate for evaluating treatment success. By examining various clinical factors, including symptoms and radiographic findings, the research seeks to improve treatment strategies and patient management. The goal is to address the significant unmet needs in managing this condition and to support the development of new therapeutic options.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with pulmonary Mycobacterium avium complex who are experiencing chronic respiratory symptoms.
Not a fit: Patients with acute respiratory infections or those not diagnosed with pulmonary Mycobacterium avium complex may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and better quality of life for patients suffering from chronic lung infections.
How similar studies have performed: Previous research has shown that developing validated outcome measures can significantly enhance the management of chronic diseases, suggesting potential success for this approach.
Where this research is happening
PORTLAND, UNITED STATES
- OREGON HEALTH & SCIENCE UNIVERSITY — PORTLAND, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: VARLEY, CARA — OREGON HEALTH & SCIENCE UNIVERSITY
- Study coordinator: VARLEY, CARA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.